Amplia Therapeutics Limited (ASX:ATX)

Amplia Therapeutics Statistics

Total Valuation

ASX:ATX has a market cap or net worth of AUD 69.26 million. The enterprise value is 41.75 million.

Market Cap	69.26M
Enterprise Value	41.75M

Important Dates

The last earnings date was Friday, May 29, 2026.

Earnings Date	May 29, 2026
Ex-Dividend Date	n/a

Share Statistics

ASX:ATX has 513.07 million shares outstanding. The number of shares has increased by 53.03% in one year.

Current Share Class	513.07M
Shares Outstanding	513.07M
Shares Change (YoY)	+53.03%
Shares Change (QoQ)	+18.22%
Owned by Insiders (%)	10.71%
Owned by Institutions (%)	7.04%
Float	434.56M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	12.62
PB Ratio	1.75
P/TBV Ratio	2.20
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	-5.42
EV / Sales	7.60
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	-4.76

Financial Position

The company has a current ratio of 19.78, with a Debt / Equity ratio of 0.01.

Current Ratio	19.78
Quick Ratio	19.54
Debt / Equity	0.01
Debt / EBITDA	n/a
Debt / FCF	-0.04
Interest Coverage	-442.65

Financial Efficiency

Return on equity (ROE) is -25.48% and return on invested capital (ROIC) is -15.80%.

Return on Equity (ROE)	-25.48%
Return on Assets (ROA)	-14.93%
Return on Invested Capital (ROIC)	-15.80%
Return on Capital Employed (ROCE)	-19.34%
Weighted Average Cost of Capital (WACC)	1.87%
Revenue Per Employee	n/a
Profits Per Employee	n/a
Employee Count	n/a
Asset Turnover	0.17
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +172.73% in the last 52 weeks. The beta is -0.43, so ASX:ATX's price volatility has been lower than the market average.

Beta (5Y)	-0.43
52-Week Price Change	+172.73%
50-Day Moving Average	0.16
200-Day Moving Average	0.15
Relative Strength Index (RSI)	44.99
Average Volume (20 Days)	891,839

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, ASX:ATX had revenue of AUD 5.49 million and -7.71 million in losses. Loss per share was -0.02.

Revenue	5.49M
Gross Profit	5.10M
Operating Income	-7.69M
Pretax Income	-7.71M
Net Income	-7.71M
EBITDA	-7.68M
EBIT	-7.69M
Loss Per Share	-0.02

Balance Sheet

The company has 27.85 million in cash and 341,111 in debt, with a net cash position of 27.51 million or 0.05 per share.

Cash & Cash Equivalents	27.85M
Total Debt	341,111
Net Cash	27.51M
Net Cash Per Share	0.05
Equity (Book Value)	39.47M
Book Value Per Share	0.08
Working Capital	31.37M

Cash Flow

In the last 12 months, operating cash flow was -8.73 million and capital expenditures -33,301, giving a free cash flow of -8.77 million.

Operating Cash Flow	-8.73M
Capital Expenditures	-33,301
Depreciation & Amortization	13,625
Net Borrowing	-71,667
Free Cash Flow	-8.77M
FCF Per Share	-0.02

Margins

Gross margin is 92.98%, with operating and profit margins of -140.06% and -140.38%.

Gross Margin	92.98%
Operating Margin	-140.06%
Pretax Margin	-140.38%
Profit Margin	-140.38%
EBITDA Margin	-139.81%
EBIT Margin	-140.06%
FCF Margin	n/a

Dividends & Yields

ASX:ATX does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-53.03%
Shareholder Yield	-53.03%
Earnings Yield	-11.13%
FCF Yield	-12.66%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

The last stock split was on April 30, 2018. It was a reverse split with a ratio of 0.1.

Last Split Date	Apr 30, 2018
Split Type	Reverse
Split Ratio	0.1

Scores

Altman Z-Score	n/a
Piotroski F-Score	1